Orphan Drug Designation in South Korea (MFDS)
Orphan Drug Designation (ODD) is regulated by Ministry of Food and Drug Safety (MFDS) in South Korea under the Pharmaceutical […]
AI Technology
Artificial Intelligence Impact on Global Pharma Regulatory Affairs
Artificial Intelligence (AI) has been making significant strides across various sectors, and the pharma industry is no exception. One area
Regulatory Intelligence In Product Registration
Today ‘s age of AI has brought in tremendous success almost in every stream. Remarkably, AI has achieved tremendous success
Artificial Intelligence (AI) and Machine Learning (ML) in Drug Discovery
Artificial Intelligence (AI) and Machine Learning (ML) in drug discovery offer new possibilities for accelerating the drug development and improving
AI For Monitoring Regulatory Updates In Pharmaceuticals & Medical Devices
Regulations in pharma and medical devices don’t stand still. They change as new technologies come in, as authorities learn from
Competitive Intelligence for a Global Anti-Depressant Drug Manufacturer
Artixio’s competitive intelligence experts are seasoned in developing comprehensive strategy across therapeutic areas, treatment modalities, and product types in global